Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.

Chagas disease is a neglected tropical disease caused by Trypanosoma cruzi. Because current treatments present several limitations, including long duration, variable efficacy and serious side effects, there is an urgent need to explore new antitrypanosomal drugs. The present study describes the hit-to-lead optimization of a 2-aminobenzimidazole hit 1 identified through in vitro phenotypic screening of a chemical library against intracellular Trypanosoma cruzi amastigotes, which focused on optimizing potency, selectivity, microsomal stability and lipophilicity.

2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.

Leishmaniasis is a major infectious disease with hundreds of thousands of new cases and over 20,000 deaths each year. The current drugs to treat this life-threatening infection have several drawbacks such as toxicity and long treatment regimens. A library of 1.

Sub-100 nm anisotropic gold nanoparticles as surface-enhanced Raman spectroscopy substrates.

This study describes a reliable preparation of relatively small Ag/Au-based anisotropic nanostructures possessing tunable absorption bands and their use as surface-enhanced Raman spectroscopy (SERS) substrates. These Au nanostructures were prepared via the seed growth process of small Ag-core-Au-shell-type nanoparticles that were obtained by the subsequent reduction of Ag and Au ions by NaBH(4) and L-ascorbic acid at room temperature. The presence of Ag during the transformation process of the Ag-Au core-shell nanoparticles under light irradiation led to the formation of various small anisotropic Au nanoparticles which clearly exhibited different structural and optical properties from those of nanoparticles prepared from typical Ag-Au alloy or bare Ag or Au seeds.